论文信息 - Paraneoplastic hypoglycaemia secondary to IGF-2 secretion from a metastatic gastrointestinal stromal tumour - 字舞流文

Paraneoplastic hypoglycaemia secondary to IGF-2 secretion from a metastatic gastrointestinal stromal tumour

H. Randeva | A. Grossman | C. Kosmas | G. Dimitriadis | Michael C. Onyema | Eftychia E. Drakou | N. Murthy | R. Ganguly | Bianca M. Leca | Georgios Giovos

[1] C. Gomez-Sanchez,et al. Non-islet Cell Hypoglycemia: Case Series and Review of the Literature , 2019, Front. Endocrinol..

[2] G. Castellani,et al. Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene , 2018, International journal of molecular sciences.

[3] Xiujie Shan,et al. Doege–Potter syndrome , 2017, Medicine.

[4] H. Randeva,et al. Paraneoplastic endocrine syndromes. , 2017, Endocrine-related cancer.

[5] G. Frezza,et al. Radiotherapy in the management of gist: state of the art and new potential scenarios , 2017, Clinical Sarcoma Research.

[6] H. Randeva,et al. Severe paraneoplastic hypoglycemia secondary to a gastrointestinal stromal tumour masquerading as a stroke , 2015, Endocrinology, diabetes & metabolism case reports.

[7] D. Leroith,et al. Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory, and the historical archive. , 2013, Endocrine reviews.

[8] J. Domański. [Paraneoplastic endocrine syndromes]. , 1989, Wiadomosci lekarskie.